Letters

Intracranial hypertension and nasal fluticasone propionate

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7314.694 (Published 22 September 2001) Cite this as: BMJ 2001;323:694
  1. Michael Oko, specialist registrar in otolaryngology (cybersurgeon@moko.freeserve.co.uk),
  2. Andrew Johnston, consultant otolaryngologist,
  3. Iain R C Swan, senior lecturer in otolaryngology
  1. Monklands Hospital, Monkscourt Avenue, Airdrie ML6 OJS
  2. Glasgow Royal Infirmary, Glasgow G31 2ER

    EDITOR—Bond et al said that nasal fluticasone propionate caused benign intracranial hypertension in a 13 year old boy with a history of Crohn's disease and subsequently reported this to the Committee on Safety of Medicines.1 We have numerous problems with this hypothesis. Firstly, Bond et al did not confirm the diagnosis of intracranial hypertension as the cerebrospinal fluid pressure, which should be markedly raised, was not measured on …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe